(Q35112381)

6 August 2017

title

Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani (English)

1 reference

6 August 2017

0 references

1 reference

1 reference

Leishmania donovani

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Ganesh Chandra Sahoo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Krishna Pandey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Vnr Das

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Pradeep Das

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

6 March 2014

1 reference

6 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

383-388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24601828%20AND%20SRC:MED&resulttype=core&format=json

Drug resistance in leishmaniasis

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

Interaction of Leishmania with the host macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

Imported visceral leishmaniasis: diagnostic dilemmas and comparative analysis of three assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

Liposomes and nanoparticles as vehicles for antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

Secretory pathway of trypanosomatid parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271

Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2014.891271